Mercaptopurine (6-MP)
Updated September 2026.
Also known as: 6-MP, Purixan, Purinethol
The nightly maintenance pill. Fakes a DNA building block; the dose is tuned to blood counts.
Mercaptopurine (6-MP) is the nightly pill of maintenance. It is a look-alike of the purine building blocks of DNA. Cells take it in and, over several steps, convert it into thioguanine nucleotides that get built into the DNA copy.
The cell’s proofreading system notices something is wrong but cannot fix it, and after repeated failed repairs the cell dies. Because it works slowly and only on cells that are dividing, it suits years of low daily doses. How fast a child’s body processes it varies a lot from person to person (two genes, TPMT and NUDT15, matter most), which is why the dose is tuned to blood counts and sometimes to a genetic test.
I made an everyday analogy and a more scientific visualization of mercaptopurine.
Everyday analogy
Mercaptopurine is like faulty bricks that stop a building project.
1 / 3 Build with faulty bricks
Build with faulty bricks
2 / 3 Reject the damaged building
Reject the damaged building
3 / 3 Stop and take it down
Stop and take it down
Teal bricks = faulty DNA building blocks formed when mercaptopurine is changed into active forms inside a cell.
Bricks = the building blocks used to make DNA, the cell’s instructions.
Building work = copying DNA so a cell can divide. Faulty blocks can disrupt copying and stop a cell dividing.
The inspector’s decision and demolition = growth stopping and a damaged cell dying, not extra medicines or an immune-cell attack. This shows one part of how mercaptopurine works.
Press play below for a more accurate visualization.
Interactive visual
How a daily mercaptopurine tablet becomes a fake DNA letter inside leukemia cells
Side effects
The full list, kept up to date:
- Mercaptopurine — Together by St. Jude · written for families by a children's cancer hospital
- Mercaptopurine — MedlinePlus · U.S. National Library of Medicine
Where I read this
- FDA prescribing information on DailyMed · section 12.1, mechanism of action
- Childhood ALL treatment (PDQ), National Cancer Institute · where each drug fits in treatment
